Floatz logo

Chloroquine

Glioma

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Small moleculePhase 1/2Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
34/ 100
Competitive Position
73/ 100

Competitive context

82 Active assets in the Glioma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Kailin Yang, MD, PhD
Phase 3B
Irinotecan
Kailin Yang, MD, PhD
Phase 3B
DIANHYDROGALACTITOL
Kintara Therapeutics, Inc.
Phase 2B
Cyclophosphamide
Essen Biotech
Phase 2B
CARMUSTINE
University of California, Davis
Phase 3B

View all 50 →

Same molecule, other indications

Chloroquine is also rated in:

glioblastomaDormant
B
Indicative ·
58 / 100
View asset →
hypertensive disorderDormant
CCC
Indicative ·
52 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →